Abstract | Invariant natural killer T cells (iNKT cells) are an innate-like T cell subset that expresses an invariant T cell receptor (TCR) α-chain and recognizes lipids presented on CD1d. They secrete diverse cytokines and can influence many types of immune responses. Despite having highly similar TCR specificities, iNKT cells differentiate in the thymus into distinct subsets that are analogous to T helper 1 (T H 1), T H 2 and T H 17 cell subsets. Additional iNKT cell subsets that may require peripheral activation have also been described, including one that produces IL-10. In general, iNKT cells are non-circulating, tissue-resident lymphocytes, but the prevalence of different iNKT cell subsets differs markedly between tissues. Here, we summarize the functions of iNKT cells in four tissues in which they are prevalent, namely , the liver, the lungs, adipose tissue and the intestine. Importantly , we explain how local iNKT cell responses at each site contribute to tissue homeostasis and protection from infection but can also contribute to tissue inflammation and damage.
. This TCR comprises an invariant TCR α-chain (TCRα), which is formed by a conserved TCRα variable (TRAV) and TCRα joining (TRAJ) gene rearrangement. The TCR β-chain (TCRβ) is formed from a limited number of TCRβ variable (TRBV) segments, but it contains substantial diversity in its complementarity-determining region 3 (CDR3) owing to different variable β (Vβ)-diversity β (Dβ)-joining β (Jβ) gene rearrangements. These semiinvariant TCRs recognize lipids presented by CD1d, a non-polymorphic MHC class I-like antigen-presenting molecule [3] [4] [5] . CD1d-binding lipid antigens from various commensal and pathogenic microorganisms have been well characterized [6] [7] [8] [9] ; however, iNKT cells are also self-reactive, and several self-lipid antigens have been reported as well 6, [9] [10] [11] [12] . A number of additional properties distinguish iNKT cells from peptide-reactive TCRαβ + T cells. First, their specificity is highly conserved when different mammalian species are compared 13 . Second, they have a different developmental pathway in the thymus that includes positive selection by thymocytes instead of by cortical epithelial cells 14 . This pathway imparts an antigen-experienced phenotype and functional maturity to iNKT cells, even before they exit the thymus. Third, iNKT cells respond very rapidly to TCR and/or cytokine signals with an immediate and copious production of cytokines. Such rapid responses allow iNKT cells to bridge innate and adaptive immune responses or even to participate in the innate response.
Fourth, as discussed in more detail below, iNKT cells are tissue homing and tissue resident. Indeed, over the past 20 years, these cells have been found to play crucial roles in a variety of immune responses and pathological conditions ( Fig. 1 ; Table 1) Although iNKT cells play important roles in numerous lymphoid and non-lymphoid tissues, in this Review, we focus on four peripheral non-lymphoid tissue locations where these cells have been best characterized, namely, liver, lungs, adipose tissue and intestine (Fig. 1) . We discuss the iNKT cell subset composition and sub-tissue location and the crucial roles of iNKT cells within each tissue. We describe the complexity of the iNKT cell response and explain how, within the same tissue, iNKT cells can serve protective roles against harmful pathogens and contribute to tissue homeostasis, yet also in some cases cause pathologic tissue damage. This could have considerable therapeutic implications. As CD1d is non-polymorphic, adoptive cell transfers using iNKT cells will not cause graft-versus-host disease. Therefore, the therapeutic use of stimulated or expanded iNKT cell populations, most recently as a platform for chimeric antigen receptors, is an area of active investigation [15] [16] [17] [18] (box 1).
Functional subsets of iNKT cells
Thymic origin and post-thymic tissue localization. In mice, iNKT cells differentiate in the thymus into at least three effector subsets, which resemble subsets of CD4 + T helper cells and also subsets of innate lymphocyte cells (ILCs) [19] [20] [21] [22] [23] [24] . Functional iNKT cell subsets can be distinguished on the basis of their expression of different cell surface markers and signature transcription factors (Table 2 ). For example, NKT1 cells are similar to T helper 1 (T H 1) cells and group 1 ILCs (ILC1s) in that they express similarly high amounts of the transcription factor T-bet (encoded by TBX21) and secrete IFNγ following activation. NKT1 cells also show greater cytotoxic function than other iNKT cell subsets. A notable unique feature of NKT1 cells, which distinguishes them from T H 1 cells or ILC1s, is that they can produce IL-4 in addition to IFNγ when activated through their TCR. NKT2 cells secrete cytokines that include IL-4 and IL-13 and therefore resemble T H 2 cells, whereas NKT17 cells are similar to T H 17 cells with regard to their cytokine secretion profile (Table 2 ). In addition to showing differences in cytokine production, thymic iNKT cell subsets express distinct chemokine receptors and integrins, suggesting that they localize to different tissue sites after exiting the thymus. In humans, functional subsets of iNKT cells are not as well defined as in mice, although there is evidence that iNKT cells in human blood that lack expression of CD4 and CD8 (double-negative (DN) iNKT cells) and those that express CD8 (either CD8αα or CD8αβ) are different from their CD4 + iNKT cell counterparts [25] [26] [27] [28] . The DN and CD8 + iNKT cells found in humans were reported to be similar to mouse NKT1 cells, showing increased IFNγ secretion and cytotoxic function when activated 26, 27 . Human iNKT cells have also been shown to be capable of producing IL-17 in a pro-inflammatory environment 29 .
Some iNKT cells remain as long-term residents in the mouse thymus 30 , where they provide important homeostatic functions. Homeostatic IL-4 production by these cells, which likely belong to the NKT2 cell subset 30 , influences the differentiation of so-called natural memory eomesodermin (EOMES)-expressing CD8 + T cells. These mature CD8 + thymocytes have an antigen-experienced phenotype typified by high levels of expression of CD44 and CD122 (also known as IL-2Rβ) 31, 32 . IL-4 secretion by thymic iNKT cells also acts on medullary epithelial cells to allow for normal egress of mature, MHC class II-restricted CD4 + T cells 33 . After they egress from the thymus, iNKT cells are largely noncirculating long-term residents in several lymphoid and non-lymphoid tissues, including the liver, lungs, spleen, lymph nodes, intestine, adipose tissue and bone marrow, as shown by parabiosis experiments in mice 34, 35 (Fig. 1 ).
There is limited understanding of what recruits iNKT cell subsets to different tissues. Within peripheral sites, iNKT cells largely do not require TCR stimulation for homeostatic maintenance and long-term survival [36] [37] [38] , a property they share with memory T cells 39, 40 . However, while iNKT cells are present in mice lacking peripheral CD1d expression, some recent studies have indicated that CD1d in the periphery is important for their full maturation; for example, expression of the natural killer (NK) receptor NK1.1 or in some tissues peripheral CD1d influences subset distribution or regulates apoptosis 37, 41, 42 . Similarly to memory CD4 + and CD8 + T cells, the homeostasis of peripheral iNKT cells depends on cytokines, with NKT1 cells dependent on IL-15 (reFs 36, 43 ). By contrast, survival and expansion of NKT17 cell populations is dependent on IL-7 (reF.
44
).
Different iNKT cell subsets are enriched in distinct tissues ( Fig. 1 ; Table 2 ). For example, NKT1 cells are highly enriched in the mouse liver 45 , while NKT17 cells are located primarily in lymph nodes, skin and the lungs, with a minor population also present in the spleen 45 . NKT2 cells populate several sites including the lung and spleen, but they are uniquely more abundant in mesenteric lymph nodes 45 . While not discussed in this Review, iNKT cells are also rapidly activated in peripheral lymph nodes and may play crucial roles in anti-pathogen responses [46] [47] [48] . Notably, the overall subset frequencies also vary between different mouse strains. For example, NKT1 cells are the most abundant subset in C57Bl/6 mice, while BALB/c mice and several other inbred strains have more NKT2 cells 45 .
Post-thymic induction of iNKT cell subsets. Although NKT1, NKT2 and NKT17 cell subsets differentiate in the thymus, there is evidence suggesting that marked post-thymic differentiation of effector iNKT cell subsets also occurs in both mice and humans 28, 49, 50 . In mice, expression of NK1.1, a hallmark of mature NKT1 cells in the thymus, was not found on recent thymic emigrants (RTEs) but was induced when the cells were exposed to CD1d in the periphery 49, 50 . Similarly, human thymic iNKT cells express low levels of CD161, a member of the NKR-P1 family related to mouse NK1.1, but they express high levels upon maturation in the periphery 51, 52 . Furthermore, using intra-thymic www.nature.com/nri fluorescein isothiocyanate (FITC) injection in mice to label iNKT cell RTEs, these cells were found to be not only NK1.1 -but also more proliferative, and upon in vitro activation, they secreted more IL-4 (reF.
50
). In the RTE population, a higher percentage also expressed neuro pilin 1 (NRP1) and produced IL-17 (reF.
). These data indicate that the iNKT cell RTEs are not representative of the mature iNKT cell populations found in the thymus, liver or spleen at steady state, suggesting that they are less mature and subject to further differentiation signals in the periphery.
Follicular helper NKT (NKT FH ) cells have been described, and they are similar to T follicular helper (T FH ) cells that act in germinal centres to promote affinity maturation of antibodies 53, 54 (box 2). IL-10-producing NKT (NKT10) cells that resemble type 1 regulatory T cells have also been characterized 34, 55, 56 .
These iNKT cell populations have been identified in the periphery, with NKT10 cells highly enriched in adipose tissue 34, 55, 56 and NKT FH cells primarily localized in the spleen, but they have not been found in the thymus of wild-type mice. However, in analyses of TCRβ mutant mice that have a β-chain substitution affecting TCRα and TCRβ pairing, IL-10-producing iNKT cells were found in the thymus and were increased in adipose tissue 57 . These data suggest that the quality of TCR signalling in the thymus influences the frequency of these cells. In wild-type mice, both NKT FH and NKT10 cells expanded after immunization with highly potent glycolipid antigens, either owing to proliferation of rare precursors or conversion from other subsets 34, 53, 56 . Notably, NKT10 cells were transcriptionally and functionally distinct from other iNKT cell subsets and had a regulatory phenotype. Promyelocytic leukaemia factor 59, 60 ) and IL-22 (reFs 61, 62 ), even in the absence of IL-17 secretion 63 . Finally, FOXP3 expression by iNKT cells has been reported following their exposure to transforming growth factor-β (TGFβ) 64 .
Activation by antigen and cytokines. Within different tissues, iNKT cells can be activated by CD1d-mediated presentation of foreign or self-antigens, which can be augmented by cytokine stimulation. They can also be activated by cytokines when TCR stimulation is absent, at least for NKT1 cells exposed to lipopolysaccharide (LPS) or IL-12 in combination with other cytokines, such as IL-18 (reFs 65, 66 ). A similar, cytokine-dependent activation of human iNKT cells has been reported 67 , although these cells may have recently undergone TCR-dependent stimulation owing to CD1d presentation of self-antigens 68 . When stimulated by cytokines in the absence of concomitant TCR stimulation, iNKT cells produced IFNγ, but they did not secrete other cytokines normally induced by the TCR, such as IL-4. TCR stimulation led to rapid, robust secretion of a variety of cytokines, which induced the activation of most other haematopoietic cells, including iNKT cells, NK cells, macrophages, dendritic cells (DCs), B cells and T cells. Which cytokines are prevalent is influenced by the proportion of iNKT cell subsets that are activated ( Table 2) . The different tissue-homing preferences of the iNKT cell subsets therefore will have strong implications for how iNKT cell activation ultimately influences local immune responses.
Liver iNKT cells Tissue residence and patrolling by liver iNKT cells.
Comparing all tissues in mice, iNKT cells are most frequent in the liver. NKT1 cells account for up to 40% of all intrahepatic lymphocytes, while the other iNKT cell subsets constitute a small fraction of the total lymphocyte count 35, [69] [70] [71] . In the human liver, iNKT cells are also enriched but much less abundant than in mice; they have been reported to account for as much as 3-5% of intrahepatic T cells 72, 73 . Several factors are important for the trafficking and long-term maintenance of liver iNKT cells, including IL-7 (reF.
74
), IL-15, the transcription factors homologue of BLIMP1 in T cell (HOBIT; also known as ZNF683), β-interferon gene positive regulatory domain I-binding factor (BLIMP1; also known as PRDM1), inhibitor of DNA binding 2 (ID2) and the cellular adhesion molecules intercellular adhesion molecule 1 (ICAM1) and lymphocyte function-associated antigen 1 (LFA1) 35, [75] [76] [77] [78] [79] . The chemokine receptor CXC-chemokine receptor 6 (CXCR6) is important for survival and maintenance of iNKT cells in the liver 35, [75] [76] [77] [78] [79] . CD69 is important for tissue residence of a variety of T cell populations, and CD69, along with HOBIT and BLIMP1, has been shown to be increased on non-circulating iNKT cells in the liver. HOBIT and BLIMP1 cooperate to maintain tissue residence by downregulating genes involved in tissue egress 80 . ID2 was shown to increase expression of CXCR6 by hepatic iNKT cells 79 . Blockade of LFA1 and ICAM1 reduced accumulation of iNKT cells in the liver and allowed for recirculation of liver iNKT cells in parabiotic mice 35 . At steady state, intravital microscopy studies have shown that iNKT cells patrol the liver sinusoids through a random, crawling motion both with and against the direction of blood flow 76 ( Fig. 2a) . Activation of the TCR, exposure to inflammatory cytokines such as IL-12 and IL-18 or tissue infection can trigger the arrest of patrolling iNKT cells on sinusoids 66, 76, 81 (Fig. 2b ).
CD1d is highly expressed on sinusoid-lining endothelial cells and, to a lesser extent, on Kupffer cells, the
Box 1 | iNKT cells are a promising target for immune therapies
Several features of invariant natural killer T (iNKT) cells make them a promising and versatile target for immune therapy. First is their 'one-size fits all' specificity, meaning an effective glycolipid antigen for iNKT cells will work in everyone. Second, because CD1d is not polymorphic 13, 183, 184 , transferred iNKT cells will not cause graft-versus-host disease. Additionally, iNKT cells have strong effector function, they are tissue homing, they are self-renewing in the periphery, and they can be grown rapidly in vitro. Much of the clinical and biotech effort has been on boosting the immune response to cancer [15] [16] [17] [185] [186] [187] [188] , although rapid iNKT cell effector responses are also being tested to achieve adjuvant-like stimulation of vaccine responses [189] [190] [191] [192] . Inhibition of iNKT cells may prove to be valuable for preventing inflammation in the liver or for crisis in sickle cell disease 193, 194 . These strategies are focused on the NKT1 cell-like functions of human iNKT cells, such as IFNγ production and cytotoxicity. Because their immune responses vary, iNKT cell activation is also being tested as a means to prevent graft-versus-host disease through an antigen formulation that stimulates Il-4 and other cytokines 195, 196 . The main obstacles are that iNKT cells are very infrequent in some individuals, and therefore are difficult to expand, that human responses to α-galactosyl ceramide (αGalCer) are not as robust as in mice and that the types of cytokines produced by iNKT cells vary 188, 197 . These problems may be obviated by current efforts to synthesize more potent antigens or ones that stimulate a more T helper 1 (T H 1) cell-type polarized iNKT cell response 186, 191, 198 . Alternatively, iNKT cells can be expanded in vivo by using specific anti-T cell receptor (TCR) antibodies, and ex vivo-expanded iNKT cells are being tested as a cancer treatment 199, 200 . iNKT cells may also be a useful platform for expression of chimeric antigen receptors (CARs); for example, a CAR that is specific for neuroblastomas would target these cells and, at the same time, the natural CD1d autoreactivity of the iNKT cells enables them to kill suppressive tumour-associated macrophages [15] [16] [17] [18] . Time will tell whether any of these diverse strategies will provide an effective immune therapy.
www.nature.com/nri macrophages of the liver and tissue-resident and circulating DCs 76 . CD1d-mediated antigen presentation by several cell types can lead to activation and arrest of patrolling iNKT cells. Hepatocytes and stellate cells also express CD1d. These cells can present antigens to iNKT cells that enter the tissue, or they may interact with sinusoidal iNKT cells through openings in the endothelium 41, 82 ( Fig. 2) . Notably, very recent data showed that hepatocyte-specific CD1d expression regulated hepatic iNKT cell homeostasis 41 . This function was dependent on the microsomal triglyceride transfer protein (MTP), which is involved in transfer of lipids onto CD1d in the endoplasmic reticulum. Absence of MTP or a hepatocyte-specific loss of CD1d was associated with a liver-specific increase in iNKT cell numbers, reduced iNKT cell apoptosis and a higher susceptibility to iNKT cell-mediated hepatitis 41 .
Hepatic iNKT cells protect from infections.
Because of their prevalence in the liver, there are many examples in which iNKT cell activity plays an important role in local immune and inflammatory responses (Table 1) . iNKT cell activation can be protective, as long as it is not chronic or excessive, as over activation leads to destructive tissue damage. One particularly wellstudied example of beneficial liver iNKT cell activation is the response to Borrelia burgdorferi infection (Fig. 2c) . B. burgdorferi is a spirochaete that is the causative agent of Lyme disease. It expresses a well-characterized glycolipid antigen for iNKT cells 7, 81, 83 . After infection, patrolling liver iNKT cells slow their sinusoidal patrolling, with 80% of the iNKT cells becoming completely stationary within 5 hours 81 . At 8 hours, these arrested iNKT cells were found in intimate clusters with Kupffer cells in the liver sinusoids, which was dependent on surface expression of CXCR3 by iNKT cells, as well as Kupffer cell expression of CD1d and release of the CXCR3 ligand CXC-chemokine ligand 9 (CXCL9) 81 . At this time, CD69 was upregulated and IFNγ was produced by the iNKT cells 7, 81 . Interestingly, while α-galactosyl ceramide (αGalCer) injection also induced arrest of iNKT cells and production of IFNγ and IL-4, it did not induce clustering with Kupffer cells 81 . This suggests that CD1d on other cell types also induces iNKT cell arrest in the vasculature, and it illustrates the important differences revealed when comparing the response to a pathogen versus a synthetic iNKT cell antigen 76, 81 . When iNKT cell-deficient mice were infected with B. burgdorferi, there was a higher accumulation of spirochaetes in the joints, bladder, heart and liver, suggesting that iNKT cells help limit emigration of the spirochaetes out of the vasculature 81, 84, 85 . Joint inflammation was more pronounced in iNKT cell-deficient BALB/c mice, while carditis was more evident in iNKT cell-deficient C57Bl/6 mice [84] [85] [86] . IFNγ production by iNKT cells was increased after infection, and it probably plays a role in host protection in both the liver and the heart 84, 85 . Similar protective effects have been shown in various hepatitis virus models. NKT1 cells inhibited hepatitis C virus (HCV) replication in the mouse liver, which also occurred through IFNγ production 87 . Humans with chronic HCV infection showed significantly reduced numbers of iNKT cells in the liver and peripheral blood compared with healthy controls in some studies 88, 89 , but this was not found in others 90 . The low frequencies of circulating iNKT cells in patients with chronic hepatitis B increased to normal levels when they achieved viral control 91 . Furthermore, in mouse models of expression of hepatitis B virus (HBV) antigens, HBV infection through adenoviral delivery increased the production of autologous ligands that activate iNKT cells, and the absence of these cells led to reduced viral control 92 . Altogether, these data suggest a positive role for iNKT cells in protection against liver pathogens. • T-bet
• IL-13 [19] [20] [21] 24 NKT17 cells
NKT FH cells BCL-6
BCL-6, B cell lymphoma 6 protein; CCR6, CC-chemokine receptor 6; CXCR , CXC-chemokine receptor ; E4BP4, E4 promoter-binding protein 4; GM-CSF, granulocyte-macrophage colony-stimulating factor ; ICOS, inducible T cell costimulator ; iNKT cell, invariant natural killer T cell; NKT FH cell, follicular helper natural killer T cell; NRP1, neuropilin 1; PD1, programmed cell death 1; PLZF, promyelocytic leukaemia factor ; TNF, tumour necrosis factor.
α-Galactosyl ceramide (αgalCer). a glycosphingolipid that is a specific and highly potent activator of invariant natural killer T cells.
Hepatic iNKT cells play protective and contributory roles during inflammation.
In the case of chronic infections or chronic inflammation, even sterile inflammation, iNKT cell activity can be the cause of serious tissue damage. Injection of αGalCer-activated iNKT cells induced lethal inflammation in mice through the iNKT cell-mediated release of IFNγ, which stimulated the recruitment and activation of T H 1 cells and CD8 + cytotoxic T lymphocytes. This T H 1 cell-type immune bias was also mediated by interactions between CD40 ligand (CD40L), which is increased on iNKT cells upon activation, and CD40 on DCs 72 . This interaction led to IL-12 production by DCs, which enhanced the cytotoxic effects of iNKT cells against hepatocytes 72 . Activated iNKT cells also caused hepatocyte death directly through increased FAS antigen ligand (FASL) expression as well as by the release of tumour necrosis factor (TNF), perforins and granzyme B 72, 93 (Fig. 2d) .
Interestingly, following concanavalin a (Con A) injection, increased FASL also led to apoptosis of iNKT cells 93 , a process that was dependent on CC-chemokine receptor 5 (CCR5) expression by iNKT cells and suppression of their IL-4 production 94 .
In models of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), activation of the immune system contributed to progression of fatty liver damage. Because iNKT cells respond to lipid antigens and can exhibit cytotoxicity against hepatocytes, they have become a focus of research in this area. NASH-like liver pathology can be induced by choline-deficient, methionine choline-deficient or high-fat high-cholesterol diets, which led in each case to increased expression of CD1d, accumulation of intrahepatic iNKT cells and, as a result, increased fibrinogenesis, higher alanine aminotransferase (ALT) levels and higher NASH disease scores 73, [95] [96] [97] (Fig. 2d) . Notably, iNKT cell-deficient mice had dramatically less fibrosis and lower disease scores 95 . In humans, a similar correlation between increased iNKT cells, increased cirrhosis and higher NAFLD disease activity has also been shown 73, 98 . Hepatic fibrosis during NASH has been shown to be dependent on IL-13, and some evidence suggests that iNKT cell-derived IL-13 contributes to this 73, 99, 100 . Similarly, using other hepatitis models, including chronic infection with hepatitis B virus and Con Ainduced hepatitis, iNKT cells promoted liver fibrosis and prevented liver regeneration 93, [101] [102] [103] . In these models, iNKT cells accumulated in the liver, upregulated CD69 and caused increased IL-12, IFNγ and TNF production 93, [101] [102] [103] [104] [105] . Pathogenesis was ameliorated when iNKT cells were blocked or removed. This was shown by depletion of NK1.1 + iNKT cells using an anti-NK1.1 antibody, by blockade of CD1d or in Traj18 −/− mice, which lack the Jα (Traj) segment required to form the invariant TCRα. These data are consistent with the hypothesis that iNKT cells promote liver damage and actively block liver regeneration in this model 93, 102, 103 . iNKT cell recruitment and liver damage were also decreased in Con A-injected peroxisome proliferator-activated receptor-α (PPARα)-deficient mice, suggesting a role for PPARα in iNKT cell-mediated liver damage 105 . Comparable results were observed in a mouse model of primary biliary cirrhosis (PBC), where diseased mice had more iNKT cells, with increased CD69 expression and IFNγ production, which exacerbated liver injury 106, 107 . These findings correlated with human data, which showed significantly higher numbers of circulating and liver-resident iNKT cells in patients with PBC 108 . During sterile hepatic injury caused by ischaemia reperfusion, there was an influx of iNKT cells, which contributed to tissue damage through IFNγ production . These damaging immune responses were dampened by co-transfer of mesenchymal stem cells (MSCs), which induced an increase in serum IL-10 levels 110 . A similar effect was seen in an iNKT cell antigen-dependent acute liver injury 53, 201 .Furthermore, the NKT FH cells established prolonged contact with B cells 53 . These cells show similar phenotypes and localization patterns to follicular helper T (T FH ) cells, with shared features including expression of CD4, CXC-chemokine receptor 5 (CXCR5) and programmed cell death 1 (PD1), and they could be found in germinal centres following immunization with αGalCer
53
. Also similar to T FH cells, the development of NKT FH cells is dependent on expression of the transcription factor B cell lymphoma 6 (BCl-6), CD28-mediated costimulation and the presence of B cells 53 . NKT FH cells were also found in human tonsil, where approximately 10% of the iNKT cells had high co-expression of PD1 and CXCR5 (reF.
). Immunization with αGalCer linked to the hapten nitrophenyl led to antigen-specific germinal centre formation by 3 days, and NKT FH cells produced Il-21 by day 5 (reF.
This is a faster rate than conventional T cells, which typically take 10 days after protein antigen immunization, and is more similar to kinetics of T cell-independent germinal centres 53 . There is limited evidence of invariant natural killer T (iNKT) cells driving long-term IgG responses. While cognate NKT FH cells drove plasmablast and germinal centre formation, affinity maturation and a robust primary IgG antibody response dependent on iNKT cell-derived Il-21, NKT FH cells could not generate long-lived plasma cells or memory B cells 53, 54 . 202 . However, these responses were largely extrafollicular, and there was minimal NKT FH cell differentiation 202 . It is notable that iNKT cells also provide non-cognate B cell help, as shown by the role of iNKT cell-derived Il-4 in promoting germinal centre formation during influenza infection (MDSCs) from anti-inflammatory to pro-inflammatory function, thereby contributing to immune-mediated damage 111 . The results from some studies indicate that liver regeneration following partial hepatectomy is promoted by iNKT cells 112 , or at least that it is CD1d-dependent 113 . Therefore, while having the potential for causing inflammatory damage, intrahepatic iNKT cells might also be intimately connected with homeostasis and regeneration of this tissue.
Notably, one study has suggested that iNKT cells also play a protective role in sterile injury healing, particularly in focal hepatic sterile thermal injury, in which healing was significantly delayed at 7 days after injury 114 . At 4 hours, iNKT cells approached the injury but made a startling 180° turn and retreated from the area 114 . At 8 hours, iNKT cells arrested and accumulated at the boundary of the injury site in a CD1d-dependent manner 114 . iNKT cells were retained there at 24 hours, which was dependent on IL-12 and IL-18, and they began producing IL-4. However, iNKT cells did not enter into the injured tissue until 48 hours 114 . The iNKT cell responses correlated with a switch from inflammatory monocytes to reparative monocytes around the lesion, which was dependent on IL-4 produced by iNKT cells 114 , altogether suggesting a T H 2 cell-biased protective role for iNKT cells in this injury repair model.
iNKT cells in the lungs
Localization in blood vessels and lung tissue. In mouse lungs, iNKT cells account for approximately 5% of resident lymphocytes, equating to 5 × 10 3 cells in C57Bl/6 mice. They establish resident, non-circulating populations within both the lung vasculature and the interstitial tissue 115 . The majority of the NKT1 and NKT2 cells were found in the vasculature and, by contrast, NKT17 cells were preferentially found within the smaller, interstitial tissue compartment 45, 115, 116 (Fig. 3) . Overall, there is a proportionally higher frequency of lung iNKT cells in the tissue than other lymphocytes in the lung 116 .
Factors required for iNKT cell homing to and maintenance within pulmonary tissue have yet to be determined. However, there is extensive evidence of the rapid extravasation of iNKT cells from the blood and into the tissue under a variety of activation conditions. Intranasal administration of αGalCer can induce iNKT cell extravasation owing to the upregulation of various chemokines, including CC-chemokine ligand 17 (CCL17), CXCL9 and CXCL13 (reFs 35, 115 ). Pulmonary infection with Francisella tularensis or Streptococcus pneumoniae has also been shown to induce iNKT cell expansion and vascular extravasation in a CCL2-dependent manner, suggesting that iNKT cells are recruited to and play a role within the lung interstitial tissue during infection [116] [117] [118] .
Protection from pulmonary infections. Similarly to infections in the liver, in several pulmonary bacterial infection models, including infections with S. pneumoniae, Listeria monocytogenes and Pseudomonas aeruginosa, iNKT cells were crucial for protection in a CD1d-dependent manner ( Fig. 3; Table 1 ). In the lungs, CD1d is expressed by several cell types, including alveolar macrophages, CD11b + DCs, CD103 + DCs and monocyte-derived DCs, all of which are potential antigen-presenting cells for iNKT cells. During S. pneumoniae infection, iNKT cells increased in number and produced IFNγ and IL-17 within 13 hours of infection 8 . During Schistosoma japonicum parasitic infection, iNKT cell numbers surprisingly decreased; however, the remaining cells were more activated, as measured by both an increase in surface CD69 and CD25 and the secretion of cytokines, including IL-17, IL-10 and IL-5 (reF.
119
Control of Aspergillus fumigatus in the lung was dependent on iNKT cells. The protective response required CD1d and IL-12, which were induced by antigenpresenting cell responses to the fungal wall β-glucan 120 .
In these infection models and several others, in the absence of iNKT cells, pathogen burden was increased and survival decreased 8, 65, 118, 121, 122 . Furthermore, inflammatory responses were generally reduced following infection in iNKT cell-deficient mice, including decreased neutrophil recruitment and decreased synthesis of pro-inflammatory CXCL2 and TNF 118, 121, 122 . These data suggest that iNKT cells play a role in protective inflammatory responses to bacteria and parasites in the lungs.
iNKT cells also undergo activation and population expansion and show protective effects in pulmonary viral infections, such as those from influenza A virus. After infection with influenza A virus, mice lacking iNKT cells (Cd1d [123] [124] [125] [126] . There are several possible roles iNKT cells could play during viral infection. Upon activation, iNKT cells produce IFNγ, which can induce T H 1 cell-biased responses; this pathway is associated with the activation of NK cells, macrophages and CD8 + T cells, all of which can aid in eliminating viruses 125 . The absence of iNKT cells also correlated with an increase in MDSCs in the lungs 123 . Adoptive transfer of iNKT cells reduced MDSC population expansion after influenza infection in a CD1d-dependent and CD40-dependent manner, suggesting that iNKT cells inhibit the immune-suppressive effects of MDSCs 123 . Additionally, iNKT cells produced IL-22 during infection, an IL-10 family cytokine that is protective against epithelial damage 63, 127 . IL-22 and iNKT cells also played a role in protection from secondary S. pneumoniae infection following influenza, consistent with a protective role for iNKT cell-derived IL-22 (reFs 126, 127 ).
iNKT cells in asthma and allergies. Activation of iNKT cells has been shown to exacerbate inflammation in the lungs in the absence of infection, as in the case of allergic asthma. Intranasal αGalCer administration led to increased numbers of iNKT cells, increased secretion of IFNγ and IL-4 by iNKT cells 
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and acute lung inflammation 128 . When αGalCer was coadministered intranasally with ovalbumin (OVA), OVA challenge led to massive eosinophilia and an asthma-like response dominated by T H 2 cell-type cytokines 115 . In the OVA-induced model of allergic asthma with methacholine challenge, iNKT cells produced IL-4, IL-5, IL-10, IL-13 and IFNγ in an inducible T cell costimulator (ICOS)-ICOS ligand (ICOSL)-dependent manner 129, 130 . In this model,
Traj18
−/− iNKT cell-deficient mice showed decreases in airway hyperresponsiveness, eosinophilia, IL-4, IL-5 and IL-13 in bronchoalveolar lavage fluid (BALF) and reduced anti-OVA IgE 130, 131 . The decreases were reversed by adoptive transfer of iNKT cells 131 . NKT17 cells were a prevalent subset within the lung tissue, and upon stimulation with αGalCer, the IL-17 they secreted recruited neutrophils into the BALF but was not required for airway hyper-responsiveness 132, 133 . As αGalCer is a highly potent antigen, the iNKT cell phenotypes seen in mouse models of asthma following exposure to αGalCer might not reflect what happens after the physiological stimulation of iNKT cells. In the absence of αGalCer, however, the induction of airway eosinophilia and mucus in response to ragweed was reduced in CD1d-deficient mice 134 , and airway hyperreactivity induced by sensitization with OVA and alum was also dependent on CD1d and iNKT cells 131, 135 . In addition, ozone-induced asthma was similarly dependent on iNKT cells and T H 2 cell cytokines but also required IL-17 (reF.
136
). Furthermore, sterile house dust extracts (HDEs) contain antigens for iNKT cells 137 , and alum adjuvant could be replaced by HDEs to sensitize for OVA-induced airway hyper-reactivity. This adjuvant-like activity of HDEs was dependent on iNKT cells 137 . iNKT cells have also been shown to play roles in driving chronic obstructive pulmonary disease (COPD). Repeated administration of αGalCer resulted in a decline of lung function and COPD-like symptoms, such as mucus hyper-secretion, fibrosis and emphysema 128 . Patients with COPD were found to have increased numbers of iNKT cells in the blood, and mice chronically exposed to cigarette smoke had increased numbers of iNKT cells in the lung 138 . These data indicate that oxidative stress may contribute to iNKT cell activation. Moreover, in a model of post-viral asthma and COPD induced by infection with Sendai virus, iNKT cells contributed to disease by inducing IL-13 production by macrophages 139 . However, despite these reports cited above, there is not universal agreement on the importance of iNKT cells for asthma models in mice. One study investigated several different models of airway disease and found no significant difference between wild-type and iNKT cell-deficient mice in any of the models tested 140 . A potential explanation for these discrepancies is differences in the microbiota, in the lung or elsewhere in the body, in different mouse colonies. Germ-free mice showed increased iNKT cells in the lung, which was attributed to increased CXCL16 expression 141 . These mice also had more severe OVA-induced asthma than specific-pathogen free (SPF) mice, suggesting a correlation between the microbiota, iNKT cells and asthma 141 . Whether the frequency of iNKT cells is increased in the lung tissue and BALF of patients with asthma has been a controversial issue 142, 143 , and it remains to be determined whether iNKT cells are relevant for the pathogenesis of human asthma.
Adipose tissue and iNKT cell function Distinct iNKT cells are found in adipose tissue. The concept that T cells that recognize self-lipids might have a special role in regulating adipose tissue is appealing, but there is no consensus on the function of iNKT cells in fat tissue. In both humans and mice, iNKT cells were found to be enriched in visceral adipose tissue (VAT), where they represented up to 15-20% of total T cells 56, [144] [145] [146] . The data on human iNKT cells is particularly striking, because they tend to be much less frequent in other sites in humans and generally less frequent than they are in mice. iNKT cells were also enriched in mouse subcutaneous, perirenal and epididymal adipose tissue 147 ; at this latter site, iNKT cells were shown to express higher amounts of CD69 and IFNγ than splenic iNKT cells 148 .
Similarly to iNKT cells in other sites, adipose iNKT cells do not recirculate 34 . Unlike in the liver, however, they do not depend on LFA1 or ICAM1 expression for their retention, and the factors required for their recruitment and retention in adipose tissue remain unknown 34 . In adipose tissues, CD1d is highly expressed on M2 macrophages and to a much lesser extent on M1 macrophages, DCs and eosinophils 149 . Adipocytes express a high amount of mRNA encoding CD1d, and they can present glycolipid antigens in vitro to iNKT cells 146 . The iNKT cells in adipose tissue are characterized by an increased frequency of IL-10-producing cells 34, 56 ; one report also described adipose tissue-associated iNKT cells as having low expression of PLZF and high expression of the transcription factor E4BP4, which induces Il10 transcription 34 . IL-10-producing iNKT cells, which are also referred to as NKT10 cells, could be induced by repeated or strong antigenic stimulation 56, 150 . Mice with a mutation in the constant region of TCRβ that influences TCRα-TCRβ pairing had a higher percentage of iNKT cells in adipose tissue, although the percentage of iNKT cells was lower in other sites, such as spleen 57 .
Adipose iNKT cells and metabolic regulation.
There are few data regarding the response to infection by iNKT cells in fat; instead, the available evidence indicates a role for iNKT cells in the homeostasis of adipose tissue. In obese humans, iNKT cells were reduced in the circulation compared with in lean, healthy, age-matched controls 144, 145 . Fewer adipose tissue iNKT cells in humans also correlated with an increased body mass index (BMI) and glucose intolerance 151 . Similarly, iNKT cells were decreased in the fat of obese mice 144, 146, 151 . iNKT cell numbers recovered in the adipose tissue of humans after bariatric surgery, and in obese mice, they increased after the animals were removed from a long-term high-fat diet (HFD) 144, 146, 151 . Taken together, these findings suggest a positive correlation between obesity and decreased iNKT cell numbers 144 , and several mechanisms have since been suggested.
One such mechanism suggests a role for iNKT cells in the 'browning' of white adipose tissue (WAT). Activation of iNKT cells with αGalCer led to significant weight loss in obese mice 147 . This correlated with an increase in thermogenesis, an overall 1 °C rise in body temperature and a significant induction of mitochondrial brown fat uncoupling protein 1 (UCP1) + cells in inguinal WAT within 24 hours of injection 147 . This browning was partially dependent on iNKT cell-induced fibroblast growth factor 21 (FGF21), which had previously been shown to induce weight loss in humans and mice 147 . Notably, this iNKT cell-induced browning mechanism was not dependent on αGalCer, and could be induced by adoptive transfer of iNKT cells into obese mice 147 . Similarly, liraglutide, a glucagon-like peptide 1 receptor (GLP1R) agonist, also led to proliferation of adipose iNKT cells and iNKT cell-dependent FGF21 induction and weight loss 147 , further suggesting that an iNKT cell-induced FGF21-mediated pathway leads to weight loss.
There are controversies regarding the regulation of the inflammatory state of adipose tissue by iNKT cells (Table 1) . In some studies of mice on a low-fat diet, which is considered to be a normal diet, adipose tissue iNKT cells had an activated phenotype, which was modulated directly by adipocytes, and they secreted IL-4 and IL-13 (reF. 152 ). Cd1d −/− mice on a normal diet had an insulin-resistant phenotype, without obvious adipose tissue inflammation, suggesting a protective role for iNKT cells in adipose tissue 152 . Similar protective effects of iNKT cells were seen following very short-term exposure of mice to a HFD, during which time iNKT cells increased in the adipose tissue and promoted M2 macrophage polarization 151, 153 . It may seem paradoxical that iNKT cells had a similar effect under both conditions, but the HFD was maintained for only 4 days in the short-term study. Cd1d −/− mice showed impaired systemic glucose tolerance and insulin sensitivity after 4 days, 8 weeks or 24 weeks of a HFD 151 . Similar effects were seen in Traj18 −/− mice. However, two studies that fed mice a HFD for a much longer time, 12-13 weeks, found a contradictory response, in which iNKT cells in the WAT and VAT drove a pro-inflammatory response, including secretion of IFNγ, IL-4 and TNF, which led to recruitment of M1 macrophages into the adipose tissue 154, 155 . This effect was exacerbated by treatment with αGalCer 154, 155 www.nature.com/nri lipid accumulation 154, 155 . Taken together, these studies suggest that iNKT cells promote tissue inflammation and insulin resistance rather than protect against their development. However, in another study, where Cd1d −/− mice were fed a HFD for 26 weeks, there was no difference in glucose or insulin tolerance, and expression of genes encoding pro-inflammatory markers was similar to controls 156 . In agreement with this neutral outcome, another group found that Traj18 −/− mice gained less weight than wild-type mice after 10 weeks on a HFD, but iNKT cells did not affect glucose clearance 157 . It is known that inflammation in fat plays a fundamental role in the development of insulin resistance 158, 159 , which is mediated by the balance of M1 and M2 macrophages in the tissue 160, 161 . M2 macrophages were enriched in lean animals and had anti-inflammatory functions by promoting the secretion of IL-4, IL-10 and IL-13. Therefore, one mechanism whereby iNKT cells influence the state of adipose tissue is through their interactions with macrophages. In an investigation in which iNKT cells were beneficial, on either a standard diet or a HFD, Traj18 −/− and CD1d −/− mice had higher levels of pro-inflammatory cytokines, higher infiltration of proinflammatory M1 macrophages in the fat and a reduction in anti-inflammatory M2 macrophages 144 . Adoptive transfer of iNKT cells or treatment with αGalCer protected mice from weight gain, increased IL-10 production, reversed glucose intolerance and improved overall metabolic health 144 . Furthermore, in vivo stimulation of adipose iNKT cells with αGalCer led to expansion of iNKT cells and production of IL-10 and IL-4, which can induce an M2 phenotype on macrophages 34, 144, 151 . Interaction with M2 macrophages induced production of IL-4 and IL-13 by iNKT cells, while interactions with M1 macrophages induced iNKT cell pro-inflammatory IFNγ production 149 . Furthermore, with in vivo Cd1d deletion specifically on M2 macrophages, using a Cd1d fl/fl mouse crossed to a Lyz2 Cre mouse strain, M2 polarization of macrophages was inhibited, and socalled meta-inflammation and glucose intolerance were promoted. Cd1d deletion on M1 and M2 macrophages had the opposite effect and promoted M2 macrophage polarization and inhibited meta-inflammation 149 . These data led to the hypothesis that iNKT cells could play a role in modulating macrophage polarization in the fat through interactions with CD1d expressed by these cells, which could have profound downstream implications for physiology.
There is also evidence that CD1d expressed by adipocytes plays a role in the regulation of metabolism, presumably by presenting autologous antigens that regulate the homeostasis of adipose tissue. Here again, however, the results from different reports are not consistent. Obesity and insulin resistance were aggravated in mice with an adipocyte-specific deletion of Cd1d after 8 weeks of HFD feeding 144, 162 , implying physiologically important antigen presentation by CD1d expressed by adipocytes in vivo. In another study, removal of CD1d expression from adipocytes reduced rather than increased obesity and insulin resistance 163 . There could be several reasons for the striking discrepancies in these results, including the genetics of the mouse strains, diet composition and the micro biome. One recent investigation has aimed to understand these opposing conclusions and found that the interactions between iNKT cells and macrophages depended on the length of time the mice were on a HFD. After 8 weeks of HFD, M2 macrophages in the visceral and subcutaneous adipose tissue had decreased expression of CD1d; however, a majority of iNKT cells were still colocalized with M2 macrophages 149 . This shifted by 16 weeks, when the M1:M2 macrophage ratio and levels of TNF and IL-1β increased, causing a shift towards iNKT cell interaction with M1 macrophages and leading to a pro-inflammatory environment 149 . These results suggest that iNKT cells play a protective role in the early stages of obesity, when they are interacting predominantly with M2 macrophages, and a pathogenic role at later stages of obesity, when they are interacting with M1 macrophages.
Intestinal iNKT cells
Intestinal iNKT cells shape the microbiota. In the intestine, variable numbers of iNKT cells have been reported, owing in part to differences in how the cells were defined. Early studies defined iNKT cells as either CD3 + NK1.1 + or TCRβ + NK1.1 + and found that they were more prevalent in the intraepithelial lymphocyte (IEL) compartment than in the lamina propria 70, 164, 165 . With the advent of CD1d tetramers, however, a more accurate detection was possible, and it was found that iNKT cells in mice were more prevalent in the lamina propria than in the epithelial layer and more highly represented in small intestine than in large intestine. Generally, iNKT cells accounted for less than 1% of the total lymphocytes in the small intestine 71, 166, 167 . In humans, iNKT cells are also mainly found within the lamina propria and estimated to represent less than 0.4% of small intestinal T cells 166 . In the human fetus, mature IFNγ-producing iNKT cells were found to be present in the small intestine by 18 weeks of gestation 168 . This suggests that iNKT cells differentiate and acquire effector functions even before establishment of the commensal microbiota.
While they arise before microbial colonization, it is clear that iNKT cells contribute to the regulation of intestinal tissue homeostasis through crosstalk with the intestinal microbiota, and the mechanisms involved have begun to be elucidated 169 . The presence of CD1d and iNKT cells in the intestine was found to alter the composition of the intestinal microbiota 42 , and CD1d expression restrained the ability of bacteria to colonize the intestine 170 by influencing Paneth cell release of antimicrobial peptides. This may be due to iNKT cell secretion of IFNγ, as this cytokine triggers release of antimicrobial peptides 171 . CD1d-deficient mice were colonized at an accelerated rate with several bacteria, including P. aeruginosa, Escherichia coli, Staphylococcus aureus and Lactobacillus gasseri 172 . iNKT cell-deficient mice also showed a significant reduction of certain unclassified members of the order Bacteroidales and members of the family Sutterellaceae 42 . This was shown to be mediated by CD1d expression by a CD11c + cell type 42 , which also played a role in physically segregating the microbiota from intraepithelial cells 42 .
Meta-inflammation
a metabolically driven, chronic, low-grade inflammation that is manifested by immune cells and adipocytes. This inflammation has been linked to obesity and insulin resistance.
Influences of the microbiota on intestinal iNKT cells.
As well as shaping the microbiota, iNKT cells are themselves influenced by the microbiota. Germ-free mice were shown to have higher numbers of iNKT cells in both the intraepithelial and the lamina propria compartments owing to increased CXCL16 expression in the intestine 141 . The iNKT cells from germ-free mice were hypo-responsive compared with those from SPF mice 141, 173 . Antibiotic-treated mice also had increased intestinal iNKT cells 174 . In the context of inflammatory disease, germ-free mice had increased morbidity in oxazolone-induced colitis 141 , an inflammatory bowel disease (IBD) model that requires iNKT cell-derived IL-13 (reFs 141, 175 ) ( Table 1) . Humans with ulcerative colitis also showed higher IL-13 production by lamina propria CD1d-reactive T cells, but these cells did not express invariant TCRα 176 . Reintroduction of a conventional microbiota to neonatal mice, but not to adult mice, normalized iNKT cell populations and reversed the susceptibility to colitis 141 . The common commensal bacteria Bacteroides fragilis produces a glycosphingolipid antigen that is structurally similar to αGalCer 177 . Monocolonization of neonatal germ-free mice with B. fragilis, or even exposure to the purified glycolipid antigen from this bacterium, restored iNKT cell numbers in the intestine to normal levels and protected them from hypersensitivity to oxazolone-induced colitis 178 . It is uncertain whether this glycolipid antigen is an antagonist, is an agonist or has mixtures of these properties 177, 178 ; this requires further investigation with synthetic rather than purified material. In another study, however, introduction of Sphingomonas spp. bacteria, which contain characterized iNKT cell antigens, to adult germ-free mice restored the maturation and responsiveness of intestinal iNKT cells 173 . Furthermore, mice that underwent short-term antibiotic treatment, followed by re-colonization through faecal transplant with a dysbiotic microbiota from mice with dextran sulfate sodiuminduced colitis, had not only an increase in intestinal iNKT cells but also an increase in the percentage of these cells that produced IFNγ 174 . Therefore, alterations in the intestinal microbiota of adult mice can affect intestinal iNKT cells, although alterations in very young mice may have more widespread and longer lasting effects.
Intestinal inflammation and infection. iNKT cells in the small intestine are also important in several other contexts. Coeliac disease is mediated by IFNγ production in response to gluten. In one study, patients with coeliac disease had increased numbers of iNKT cells in the duodenal IEL compartment, as measured by RNA expression of the invariant chain rearrangement (TRAV10-TRAJ18) 179 . This increase positively correlated with the severity of the mucosal lesions and mRNA for IFNγ 179 . However, a conflicting study found decreased numbers of iNKT cells in the duodenum of patients with coeliac disease, and these iNKT cells showed a lower cytokine-producing capacity 180 . Intestinal iNKT cells have been shown to have a pathological role in Toxoplasma gondii infection. Oral ingestion of T. gondii promotes a T H 1 cell-biased immune response in the gut, but excessive IFNγ production caused lethal, acute ileitis in C57Bl/6 mice 167 . iNKT cell-deficient Traj18 −/− mice showed decreased levels of IFNγ in the intestine, decreased ileitis and improved survival, suggesting that iNKT cells contribute to tissue damage 167 . By contrast, iNKT cells seemed to show tissue-protective functions in the intestine of Apc Min/+ mice, which spontaneously develop benign polyps, an early step in colorectal cancer carcinogenesis. Apc Min/+ mice deficient in iNKT cells had increased intestinal polyps, with iNKT cells apparently preventing polyp formation by suppressing local inflammation 181 . The iNKT cells in the polyps produced IL-10 and shared some of the phenotypical features of iNKT cells in adipose tissue 34, 55, 56, 144 . In summary, iNKT cells in the intestine can be either pro-inflammatory or anti-inflammatory, and the type of antigen-presenting cell engaging them via CD1d expression seems to be crucial for determining their function. When CD1d was deleted from CD11c + cells, there was a decrease in the frequency of NKT17 cells in the small intestine lamina propria, while NKT1 cells remained unaltered 42 , suggesting differential control of the homeostasis of iNKT cell subsets by different CD1d-expressing cell types. In another study, deletion of CD1d expression from intestinal epithelial cells contributed to increased inflammation, while deletion from bone marrow-derived cells had the opposite effect 182 . A perhaps similar phenomenon applies to the liver, where deletion of CD1d from hepatocytes leads to an increased number of intrahepatic iNKT cells and increased inflammation following Con A hepatitis 41 . Therefore, in influencing tissue homeostasis, iNKT cells interact with both haematopoietic and non-haematopoietic cell types, and CD1d expression by non-haematopoietic cells is anti-inflammatory in both the liver and the intestine.
Perspective and discussion
As described in detail above, in some contexts, iNKT cells promote host defence and inflammatory reactions in peripheral sites, whereas in other contexts, they act as regulatory cells that inhibit inflammation (Table 1) . We are just beginning to understand the mechanisms underlying this puzzling diversity of influences that iNKT cells have on the immune response. A major advance has been the finding that there are functional subsets of iNKT cells that are similar in their cytokine secretion both to T helper cell subsets and to subsets of ILCs.
Despite this progress, a number of important questions regarding the formation and stability of the iNKT cell subsets remain unanswered. First, while the transcriptomes of mature NKT1, NKT2 and NKT17 cell subsets that take up long-term residence in the thymus are known to be highly different, it remains to be determined how similar the transcriptional programmes of the peripheral iNKT cell counterparts in the circulation are. Additionally, how mature and terminally differentiated are the iNKT cells that recently emigrated from the thymus, and to what extent do they continue to differentiate in the periphery? Second, how stable are these subsets, and can they interconvert While the definition of the functional subsets of iNKT cells has provided a foundation for understanding their diverse function in different tissues, the type of activating stimulus is equally important. For example, an NKT1 cell stimulated by cytokines, such as IL-12 and IL-18, will produce IFNγ, but TCR activation of the same cell type induces a panoply of cytokines, including IL-4 and IFNγ. Therefore, understanding the role of iNKT cells in homeostasis and pathogenesis in different tissues requires not only an accounting of subset frequencies but also a systematic analysis of the local environment, including whether the iNKT cell is in blood or parenchymal tissue, the types of antigen-presenting cells and cytokines that are present and importantly the exposure of the tissue environment to microbial components, which will be very different in adipose tissue compared with liver or intestine. A deeper knowledge of iNKT cell subset formation and stability, combined with insight into the aspects of the tissue milieu, will help in understanding the immune modulatory capacity of not only iNKT cells but also other populations of innate-like T cells, such as mucosal-associated invariant T cells and γδ T cells, and undoubtedly will help efforts to use these populations in a therapeutic context (box 1).
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Mucosal-associated invariant T cells an innate-like T cell type with an invariant T cell receptor α (TCrα) chain that recognizes vitamin b metabolites presented on the MHC class ilike molecule MHC class irelated gene protein (Mr1).
